1. Global Insomnia Market Threats, Analysis, Key Players, Growth, and Forecast 2026
July 2017
Copyright © PRUDOUR 2017, All Rights Reserved

2. Overview
North America market accounts for major share in the global insomnia market, and is expected to maintain its dominance for next 10 years.
Insomnia, commonly known as sleeplessness or sleep deprivation, is a disorder wherein an individual is either unable to sleep or sleeps only partially or without adequate sleep. Insomnia affects quality of life and thought process as you feel unwell mentally and physically. Insomnia can affect people of any age and gender; however, it is more common in adult females and seriousness may increase during pregnancy, baby blues, and menopause. Insomnia is categorized into three types depending on the duration of the disorder, namely transient (few days), acute (few weeks), and chronic insomnia (few months or even years). Treatment of insomnia is given on the basis of condition or severity of disease. Common symptoms include obesity, concentration problems, reduced reaction time, memory related problems, poor immune system, daytime sleepiness, mood swings, anxiety, depression, and irritability.
Some causes of insomnia disorder include to disruption in circadian rhythm, chronic pain, hyperthyroidism, psychological stress, etc. Moreover, excessive use of drugs, such as caffeine, alcohol, and nicotine could lead to insomnia. These causes are the driving factors for growth of the global insomnia market. Other factors include technological advancements, rising demand for over-the-counter sleep aids, stressful lifestyle, job with extended periods of night shifts, environmental noise, extreme hot or cold conditions, hormonal changes, increasing number of mental disorders, Alzheimer’s and Parkinson’s disease, and sleeping next to snoring partner.
Copyright © PRUDOUR 2017, All Rights Reserved

3. Insomnia Market Overview
Details:
However, lack of awareness and education, and challenges in providing low-cost drugs coupled with highly competitive market for drugs, patent expiration, side-effects of drugs are major factors hampering market growth. As awareness regarding this condition grows, major potential can be tapped from a large undiagnosed insomnia population pool over the forecast period.
North America market accounts for major share in the global insomnia market, and is expected to maintain its dominance throughout the forecast period owing to technological advancements and rise in demand for over-the- counter drugs, followed by the market in Europe. Developing countries in Asia Pacific hold profitable opportunities for new entrants and existing vendors to invest in the countries of Asia Pacific with the elevating per capita income and upsurge in occurrence of insomnia disorder.
Copyright © PRUDOUR 2017, All Rights Reserved

4. Global Insomnia Market Segmentation
By Types of Therapy
By Drug Formulation
Pharmacological Therapy
Benzodiazepines
Non-benzodiazepines
Melatonin receptor agonists
Capsules
Tablet
Others
By Disorder Type
By Region:
Poor quality of sleep
Sleep maintenance
Other
Copyright © PRUDOUR 2017, All Rights Reserved

5. Insomnia Market Report Includes Regional Growth Rate (CAGR %)
North America
North America Insomnia Market Growth:
North America Insomnia market was valued at US$ XX billion in 2017.
Sample Text
XX.XX%
XX%
Europe
XX.XX%
XX%
Europe Insomnia Market Growth: Europe Insomnia market expected to grow at CAGR of XX% during forecast 2026.
Asia-Pacific
XX.XX%
XX%
Latin America
Asia-Pacific Insomnia Market Growth: Asia Pacific Insomnia market is expected to reach US$ XX billion over the forecast 2026.
Middle East and Africa
XX.XX%
XX%
Middle East Insomnia Market Growth:
The Middle East & Africa Insomnia market expected to cross US$ XX billion during the forecast period 2017 to 2026.
Latin America
XX.XX%
XX%
Copyright © PRUDOUR 2017, All Rights Reserved

6. Key Players Profiled Insomnia Market Include:
Key Companies Mentioned are:
Eisai Co.
Pfizer Inc.
Merck & Co. Inc.
Sanofi Pasteur
Takeda Pharmaceutical Company
Meda Consumer Healthcare Inc.
Pernix Therapeutics
Purdue Pharma L.P.
Consumer Healthcare Inc.
Dainippon Sumitomo
ECR Pharmaceuticals
Flynn Pharma
Johnson & Johnson
Astellas
Copyright © PRUDOUR 2017, All Rights Reserved

7. Research Methodology 1 3 2 4 5 6 7 1 2 3 4 5 6 7 Market profiling
In-depth secondary research is used to determine overall market size, top industry players, top products, top applications, industry connotations, identify distributors, and manufactures, etc. 1 1
Developing list of respondents
List of industry players (manufacturers, distributors, retailers and industry specialists) 3
Formulating discussion guide
PRUDOUR formulates a detailed discussion guide in order to conduct interviews with industry expert 2 2 3
Data collection
PRUDOUR conducts interviews with industry experts, industry players, distributors and retailers for data collection and verification
Data validation
Data is validated by triangulation method, in which secondary, primary and PRUDOUR analysis contribute to the final data 5 4 4
Data collection
The data is scrutinized using MS-Excel to obtain qualitative and quantitative insights about the industry 6 5
Insights
PRUDOUR delivers industry insights and information in the required format (PDF) 7 6 7
Copyright © PRUDOUR 2017, All Rights Reserved

8. Thank You
To know more about us, please visit our website:
For all sales queries or any customized research requirements us at:
For other queries contact: Lawrence John (General Manager-Business Development)
Address: Survey No. 51/14 First Floor, Vishwa Arcade,
Near Navale Lawns, Pune, Maharashtra, India
Tel.: +1 (857)
Copyright © PRUDOUR 2017, All Rights Reserved 8